Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 37 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009High Burden of Staphylococcal Disease in Indigenous CommunitiesTurnidge, J.
2012Selective inhibition of biotin protein ligase from Staphylococcus aureusSoares da Costa, T.; Tieu, W.; Yap, M.; Pendini, N.; Polyak, S.; Pedersen, D.; Morona, R.; Turnidge, J.; Wallace, J.; Wilce, M.; Booker, G.; Abell, A.
2002Prevalence of extended spectrum b-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99)Bell, J.; Turnidge, J.; Gales, A.; Pfaller, M.; Jones, R.
2005Infectious complications of traditional Samoan tattooingKorman, T.; Grayson, M.; Turnidge, J.
2011Cefazolin and enterobacteriaceae: Rationale for revised susceptibility testing breakpointsTurnidge, J.
2011Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high Vancomycin minimum inhibitory concentrationsHolmes, N.; Turnidge, J.; Munckhof, W.; Robinson, J.; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Gao, W.; Christiansen, K.; Coombs, G.; Johnson, P.; Howden, B.
2012Forgotten antibiotics: An inventory in Europe, the United States, Canada, and AustraliaPulcini, C.; Bush, K.; Craig, W.; Frimodt-Moller, N.; Grayson, M.; Mouton, J.; Turnidge, J.; Harbarth, S.; Gyssens, I.
2001Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999Gales, A.; Jones, R.; Turnidge, J.; Rennie, R.; Ramphal, R.
2005Evaluation of colistin as an agent against multi-resistant Gram-negative bacteriaLi, J.; Nation, R.; Milne, R.; Turnidge, J.; Coulthard, K.
2002Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756Bell, J.; Turnidge, J.; Jones, R.